Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Smith, M.R., Coleman, R.E., Klotz, L., Pittman, K., Milecki, P., Ng, S., Chi, K.N., Balakumaran, A., Wei, R., Wang, H., Braun, A., Fizazi, K.
Published in Annals of oncology (01.02.2015)
Published in Annals of oncology (01.02.2015)
Get full text
Journal Article
Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group
CANIL, C. M, MOORE, M. J, FISHER, B, MCKENNA, A, SEYMOUR, L, WINQUIST, E, BAETZ, T, POLLAK, M, CHI, K. N, BERRY, S, ERNST, D. S, DOUGLAS, L, BRUNDAGE, M
Published in Journal of clinical oncology (20.01.2005)
Published in Journal of clinical oncology (20.01.2005)
Get full text
Journal Article
Conference Proceeding
2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma
Petrylak, D.P, Tagawa, S.T, Kohli, M, Eisen, A, Canil, C, Sridhar, S.S, Spira, A, Yu, E.Y, Burke, J.M, Shaffer, D, Pan, C.X, Kim, J.J, Aragon-Ching, J.B, Tang, S, Zhang, H, Cavanaugh, C.T, Kauh, J.S, Walgren, R.A, Chi, K.N
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1103 POSTER Overexpression of MiR-141 and MiR-126 Distinguishes Metastatic Castration Resistant Prostate Cancer (mCRPC) From Localized Prostate Cancer (PCa) and Controls in Human Plasma
Macfarlane, R.J, Watahiki, A, Wang, Y.Z, Chi, K.N
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with de novo (D1) mCSPC vs. progression to mCSPC after localized disease (D0) at diagnosis
Bjartell, A.S., Ye, D., Agarwal, N., Chung, B.H., Given, R., Merseburger, A., Özgüroğlu, M., Juárez Soto, A., Uemura, H., Lopez-Gitlitz, A., Li, G., Mc Carthy, S., Chi, K.N., Chowdhury, S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
Taplin, M.E, Chi, K.N, Chu, F, Cochran, J, Edenfield, W.J, Antonarakis, E.S, Emmenegger, U, Heath, E.I, Hussain, A, Njar, V.C, Koletsky, A, Lipsitz, D, Nordquist, L, Pili, R, Rettig, M, Sartor, O, Shore, N.D, Marrinucci, D, Mamlouk, K, Montgomery, B
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
The Future of Systemic Therapies for Localised Prostate Cancer
Eigl, B.J, Gleave, M.E, Chi, K.N
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.08.2013)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.08.2013)
Get full text
Journal Article
7058 POSTER Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) – a Drug-Drug Interaction (DDI) Study With Dextromethorphan HBr and Theophylline
Chi, K.N, Tolcher, A, Lee, P, Rosen, P, Molina, A, Jiao, J, Bernard, A, Tran, N, Acharya, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
7056 POSTER QT/QTc Studies of Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) – Analysis of 3 Phase 1/2 Studies
Ryan, C.J, Danila, D.C, Tolcher, A, Chi, K.N, Tran, N, Knoblauch, R, Kheoh, T, Haqq, C.M, Scher, H.I, Molina, A
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
CN35 Screening recommendations for and outcomes of male patients (pts) with germline BRCA (gBRCA)
Mohamed, H.M.A., Huang, L., Sun, S.Z., Nuk, J., Schrader, K., Chi, K.N., Sun, S., Ko, J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
7014 A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive Castrate Resistant Prostate Cancer (CRPC)
Beardsley, E.K, Hotte, S.J, Ellard, S, Winquist, E, North, S, Chi, K.N
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
693P Plasma exosome microRNA-155-3p expression in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors: Potential biomarker of response to systemic therapy
Soleimani, M., Thi, M., Saxena, N., Khalaf, D.J., Eigl, B.J., Chi, K.N., Kollmannsberger, C.K., Nappi, L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial
Chi, K.N., Sandhu, S., Smith, M.R., Attard, G., Saad, M., Olmos, D., Castro, E., Roubaud, G., Pereira de Santana Gomes, A.J., Small, E.J., Rathkopf, D.E., Gurney, H., Jung, W., Mason, G.E., Dibaj, S., Wu, D., Diorio, B., Urtishak, K., del Corral, A., Francis, P., Kim, W., Efstathiou, E.
Published in Annals of oncology (01.09.2023)
Published in Annals of oncology (01.09.2023)
Get full text
Journal Article
651P Impact of abiraterone acetate plus prednisone (AAP) in patients with castration-sensitive prostate cancer (mCSPC) and visceral metastases: Subgroup analyses of the LATITUDE study
Baciarello, G., Ozguroglu, M., Mundle, S.D., Leitz, G., Richarz, U., Hu, P., Chi, K.N., Fizazi, K.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
648TiP PSMAfore: A phase III study to compare 177Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC
Morris, M.J., Sartor, O., Chi, K.N., de Bono, J.S., Shore, N.D., Crosby, M., Dalal, D., Fizazi, K.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
7024 Phase Ib dose-finding trial of intravenous (i.v.) panobinostat (PAN) with docetaxel (DOC) and prednisone (PRED) in patients (pts) with castration resistant prostate cancer (CRPC)
Vaishampayan, U, Rathkopf, D, Chi, K.N, Hotte, S, Vogelzang, N, Alumkal, J, Agrawal, M, Picus, J, Fandi, A, Scher, H.I
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)
Chi, K.N, Hotte, S.J, Yu, E, Tu, D, Eigl, B, Tannock, I, Saad, F, North, S, Powers, J, Eisenhauer, E
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article